BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $607,000 | -12.5% | 7,571 | -6.1% | 0.60% | -21.0% |
| Q2 2020 | $694,000 | +6.0% | 8,059 | 0.0% | 0.76% | -13.7% |
| Q1 2020 | $655,000 | -27.1% | 8,059 | -22.9% | 0.88% | -8.7% |
| Q4 2019 | $898,000 | -13.2% | 10,447 | -11.6% | 0.97% | -13.0% |
| Q3 2019 | $1,035,000 | -8.5% | 11,823 | -14.3% | 1.11% | -12.7% |
| Q2 2019 | $1,131,000 | +0.7% | 13,800 | 0.0% | 1.27% | -3.6% |
| Q1 2019 | $1,123,000 | +20.1% | 13,800 | -2.8% | 1.32% | +13.3% |
| Q4 2018 | $935,000 | -18.1% | 14,200 | -4.1% | 1.16% | +8.5% |
| Q3 2018 | $1,141,000 | -1.6% | 14,800 | -5.7% | 1.07% | +17.9% |
| Q2 2018 | $1,160,000 | +10.1% | 15,700 | -3.1% | 0.91% | +22.3% |
| Q1 2018 | $1,054,000 | -1.9% | 16,200 | -2.4% | 0.74% | +15.3% |
| Q4 2017 | $1,074,000 | -9.0% | 16,600 | -11.7% | 0.65% | -7.3% |
| Q3 2017 | $1,180,000 | +0.4% | 18,800 | -3.1% | 0.70% | -27.8% |
| Q2 2017 | $1,175,000 | +9.4% | 19,400 | -6.3% | 0.96% | -22.1% |
| Q1 2017 | $1,074,000 | +9.0% | 20,700 | -6.8% | 1.24% | +10.0% |
| Q4 2016 | $985,000 | +6.6% | 22,200 | +14.4% | 1.13% | +20.6% |
| Q3 2016 | $924,000 | +5.2% | 19,400 | 0.0% | 0.93% | -1.0% |
| Q2 2016 | $878,000 | – | 19,400 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |